AB Science (EUR)
AB
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 16.36 | 17.10 |
| 52-Wk Range | - | - |
| Last Close | 16.70 |
| Mkt Cap (m) | 740.71 |
| Dividend yield | - |
| ISIN | FR0010557264 |
| Volume | 270,539.00 |
| Exchange Venue | PAR |
Company Profile
AB Science is a pharmaceutical company. It is engaged in research, development, & commercialization of tyrosine kinase inhibitors, therapeutic drugs used in treating cancerous tumors, inflammatory & neuro-degenerative diseases in both humans & animals.
Key Information
| Price/Earning | - |
| Price/Book | 0.00 |
| Price/Sales | 420.16 |
| P/CF | - |
| Rev Growth (3 year avg) | - |
| EPS Growth (3 year avg) | - |
| Operating Margin % | - |
| Net Margin % | - |
| Return on Equity | - |
| Debt/Equity | - |
Financials
Income Statement
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Revenue (m) | 2.28 | 1.51 | 1.74 | 1.70 | 1.57 | - |
| Operating Income (m) | -25.96 | -30.21 | -28.40 | -28.94 | -17.47 | - |
| Net Income (m) | -26.72 | -27.70 | -27.12 | -26.06 | -21.75 | - |
| Basic EPS | -0.78 | -0.78 | -0.75 | -0.69 | -0.55 | - |
| Avg. Diluted Shares Outstanding (m) | 34.20 | 35.65 | 35.99 | 37.78 | 39.40 | - |
Balance Sheet
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Current Assets (m) | 30.60 | 36.12 | 48.64 | 20.71 | 14.09 | - |
| Non Current Assets (m) | 1.97 | 1.89 | 1.96 | 1.78 | 3.66 | - |
| Total Assets (m) | 32.58 | 38.01 | 50.60 | 22.49 | 17.74 | - |
| Current Liabilities (m) | 17.61 | 20.34 | 18.71 | 19.20 | 19.53 | - |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | -17.26 | -4.71 | 10.74 | -14.96 | -26.83 | - |
Cash Flows
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Operating Cash Flows (m) | -23.16 | -33.52 | -22.90 | -26.79 | -15.16 | - |
| Capital Expenditure (m) | -0.62 | -0.52 | -0.50 | -0.48 | -0.39 | - |
Figures are quoted in EUR unless stated otherwise
0.10 (0.60%)
€
16.80
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.